TY  - JOUR
AU  - Parra-Millán, Raquel
AU  - Jiménez-Mejías, Manuel E
AU  - Ayerbe-Algaba, Rafael
AU  - Domínguez-Herrera, Juan
AU  - Díaz, Caridad
AU  - Pérez Del Palacio, José
AU  - Pachón, Jerónimo
AU  - Smani, Younes
PY  - 2020
DO  - 10.1016/j.eimc.2020.06.002
UR  - http://hdl.handle.net/10668/22165
T2  - Enfermedades infecciosas y microbiologia clinica (English ed.)
AB  - Immune response stimulation may be an adjuvant to antimicrobial treatment. Here, we evaluated the impact of immune response modification by lysophosphatidylcholine (LPC), combined with imipenem or ceftazidime, in murine models of peritoneal sepsis...
LA  - en
KW  - Combined antimicrobial treatment
KW  - Immune response
KW  - Lisofosfatidilcolina
KW  - Lysophosphatidylcholine
KW  - Modelo de sepsis peritoneal, Modelo de neumonía
KW  - Peritoneal sepsis model
KW  - Pneumonia model
KW  - Pseudomonas aeruginosa
KW  - Respuesta inmunitaria
KW  - Tratamiento antimicrobiano combinado
TI  - Impact of the immune response modification by lysophosphatidylcholine in the efficacy of antibiotic therapy of experimental models of peritoneal sepsis and pneumonia by Pseudomonas aeruginosa: LPC therapeutic effect in combined therapy.
TY  - research article
ER  -